FDA Authorizes Merck’s COVID-19 Antiviral Pill Molnupiravir

The FDA issued emergency authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in adults age 18 and older with positive results of direct SARS-CoV-2 viral testing.